Advertisement

Topics

The U.S. FDA Completed Pre-License Inspection (PLI) of WuXi Biologics cGMP Manufacturing ...

21:23 EDT 2 Aug 2017 | BioMedReports - Blog

This is first such inspection in China. If ibalizumab is approved, the inspected facilities will be the first cGMP biologics manufacturing facilities in China

Read more...

Original Article: The U.S. FDA Completed Pre-License Inspection (PLI) of WuXi Biologics cGMP Manufacturing ...

NEXT ARTICLE

More From BioPortfolio on "The U.S. FDA Completed Pre-License Inspection (PLI) of WuXi Biologics cGMP Manufacturing ..."

Quick Search
Advertisement
 

Relevant Topic

Biotherapeutics
The field encompassing therapeutic materials produced using biological means, including recombinant DNA technology. Biotherapeutics, also known as biotech drugs or biologics, are therapies derived from living organisms. By harnessing these living cells...